​

XOMA (XOMA) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

XOMA Stock Rating

XOMA stock's rating consensus is Buy, based on 9 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (55.56%), 4 Hold (44.44%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 9 0 4 5 Strong Sell Sell Hold Buy Strong Buy

XOMA Price Target Upside V Benchmarks

TypeNameUpside
StockXOMA-
SectorHealthcare Stocks 24.81%
IndustryBiotech Stocks 65.78%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$24.60$24.60$24.60
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 25121--4
May, 25121--4
Apr, 25111--3
Mar, 25111--3
Feb, 25111--3
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jan 08, 2025H.C. WainwrightBuyBuyhold
Sep 23, 2024H.C. WainwrightBuyBuyhold
Aug 14, 2024H.C. WainwrightBuyBuyhold
Jul 09, 2024William BlairOutperformOutperformhold
Jul 09, 2024H.C. WainwrightUnderperformUnderperformhold
May 31, 2024Leerink PartnersBuyBuyhold
Apr 29, 2024H.C. WainwrightUnderperformUnderperformhold

Financial Forecast

EPS Forecast

$-5 $-4 $-3 $-2 $-1 $0 $1 $2 $3 $4 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.25$1.40$-1.50$-4.04$-1.18----
Avg Forecast$0.22$1.02$-1.97$-2.05$-1.12$-0.55$0.16$1.22$3.36
High Forecast$0.24$1.07$-1.91$-1.80$-1.12$0.17$0.64$1.99$3.40
Low Forecast$0.21$0.97$-2.04$-2.30$-1.12$-0.97$-0.35$0.45$3.32
Surprise %468.18%37.25%-23.86%97.07%5.36%----

Revenue Forecast

$0 $20M $40M $60M $80M $100M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$29.39M$38.16M$6.03M$4.76M$28.49M----
Avg Forecast$19.00M$37.37M$5.60M$6.50M$28.53M$36.20M$48.57M$65.55M$94.80M
High Forecast$19.77M$38.88M$5.76M$6.55M$30.36M$36.50M$48.57M$66.09M$95.59M
Low Forecast$18.24M$35.87M$5.49M$6.45M$26.71M$35.90M$48.57M$65.01M$94.01M
Surprise %54.66%2.13%7.63%-26.80%-0.16%----

Net Income Forecast

$-60M $-40M $-20M $0 $20M $40M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$13.30M$15.80M$-17.10M$-40.83M$-13.82M----
Avg Forecast$2.56M$11.70M$-30.00M$-46.30M$-12.85M$-6.20M$3.23M$16.95M$38.54M
High Forecast$2.70M$12.32M$-24.00M$-37.04M$-12.82M$1.95M$7.34M$22.83M$38.96M
Low Forecast$2.43M$11.09M$-35.99M$-55.56M$-12.88M$-11.13M$-4.01M$5.16M$38.13M
Surprise %419.08%35.02%-42.98%-11.82%7.56%----

XOMA Forecast FAQ

Is XOMA stock a buy?

XOMA stock has a consensus rating of Buy, based on 9 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 4 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that XOMA is a favorable investment for most analysts.

What is XOMA's price target?

XOMA's price target, set by 9 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $24.6.

How does XOMA stock forecast compare to its benchmarks?

XOMA's stock forecast shows a 0% downside, underperforming the average forecast for the healthcare stocks sector (24.81%) and underperforming the biotech stocks industry (65.78%).

What is the breakdown of analyst ratings for XOMA over the past three months?

  • June 2025: 25.00% Strong Buy, 50.00% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 25.00% Strong Buy, 50.00% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 33.33% Strong Buy, 33.33% Buy, 33.33% Hold, 0% Sell, 0% Strong Sell.

What is XOMA’s EPS forecast?

XOMA's average annual EPS forecast for its fiscal year ending in December 2025 is $-0.55, marking a -53.39% decrease from the reported $-1.18 in 2024. Estimates for the following years are $0.16 in 2026, $1.22 in 2027, and $3.36 in 2028.

What is XOMA’s revenue forecast?

XOMA's average annual revenue forecast for its fiscal year ending in December 2025 is $36.2M, reflecting a 27.08% increase from the reported $28.49M in 2024. The forecast for 2026 is $48.57M, followed by $65.55M for 2027, and $94.8M for 2028.

What is XOMA’s net income forecast?

XOMA's net income forecast for the fiscal year ending in December 2025 stands at $-6.2M, representing a -55.14% decrease from the reported $-13.821M in 2024. Projections indicate $3.23M in 2026, $16.95M in 2027, and $38.54M in 2028.